DK0512301T3 - Fremgangsmåde til påvisning af inflammation - Google Patents

Fremgangsmåde til påvisning af inflammation

Info

Publication number
DK0512301T3
DK0512301T3 DK92106707.0T DK92106707T DK0512301T3 DK 0512301 T3 DK0512301 T3 DK 0512301T3 DK 92106707 T DK92106707 T DK 92106707T DK 0512301 T3 DK0512301 T3 DK 0512301T3
Authority
DK
Denmark
Prior art keywords
cicam
amount
inflammation
patient
sample
Prior art date
Application number
DK92106707.0T
Other languages
English (en)
Inventor
Robert Rothlein
Steven D Marlin
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of DK0512301T3 publication Critical patent/DK0512301T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
    • G01N2800/245—Transplantation related diseases, e.g. graft versus host disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Rehabilitation Therapy (AREA)
  • Gynecology & Obstetrics (AREA)
  • Zoology (AREA)
  • Reproductive Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rheumatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Drying Of Semiconductors (AREA)
  • Fire-Detection Mechanisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK92106707.0T 1991-05-03 1992-04-17 Fremgangsmåde til påvisning af inflammation DK0512301T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/695,173 US5223396A (en) 1991-05-03 1991-05-03 Method for detecting organ transplant rejection

Publications (1)

Publication Number Publication Date
DK0512301T3 true DK0512301T3 (da) 1996-01-22

Family

ID=24791925

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92106707.0T DK0512301T3 (da) 1991-05-03 1992-04-17 Fremgangsmåde til påvisning af inflammation

Country Status (13)

Country Link
US (3) US5223396A (da)
EP (1) EP0512301B1 (da)
JP (1) JP3226323B2 (da)
AT (1) ATE127926T1 (da)
AU (1) AU664367B2 (da)
CA (1) CA2067916C (da)
DE (1) DE69204732T2 (da)
DK (1) DK0512301T3 (da)
ES (1) ES2077909T3 (da)
GR (1) GR3018162T3 (da)
HK (1) HK1003124A1 (da)
NZ (1) NZ242603A (da)
ZA (1) ZA923167B (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4871491A (en) * 1984-03-15 1989-10-03 Basf Structural Materials Inc. Process for preparing composite articles from composite fiber blends
US4818318A (en) * 1984-03-15 1989-04-04 Hoechst Celanese Corp. Method of forming composite fiber blends
US4874563A (en) * 1984-03-15 1989-10-17 Basf Structural Materials Inc. Process for preparing tows from composite fiber blends
US5284931A (en) 1987-05-04 1994-02-08 Dana Farber Cancer Institute Intercellular adhesion molecules, and their binding ligands
US6051231A (en) * 1988-09-01 2000-04-18 Bayer Corporation Antiviral methods and prepations
US6143298A (en) * 1988-09-01 2000-11-07 Bayer Corporation Soluble truncated forms of ICAM-1
US6514936B1 (en) 1988-09-01 2003-02-04 Bayer Corporation Antiviral methods using human rhinovirus receptor (ICAM-1)
ES2141076T3 (es) 1988-09-01 2000-03-16 Bayer Ag Proteina del receptor de rinovirus humano que inhibe la infectividad del virus.
US5324510A (en) * 1989-09-01 1994-06-28 Boehringer Ingelheim Pharmaceuticals, Inc. Use of antibodies to intercellular adhesion molecule-1 (ICAM-1) in the treatment of asthma
EP0468257B1 (en) * 1990-07-20 1999-09-01 Bayer Corporation Multimeric form of human rhinovirus receptor protein
US6107461A (en) * 1990-07-20 2000-08-22 Bayer Corporation Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use
US6130202A (en) * 1990-07-20 2000-10-10 Bayer Corporation Antiviral methods
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
US5629287A (en) * 1991-01-18 1997-05-13 University College London Depot formulations
US5223396A (en) * 1991-05-03 1993-06-29 Boehringer Ingelheim Pharmaceuticals, Inc. Method for detecting organ transplant rejection
DK145393D0 (da) * 1993-12-23 1993-12-23 Stig Haunsoe Proteinmarkoerer til forudsigelse af akut allotransplantatafstoedning
DE19631192C2 (de) * 1996-08-03 1998-09-10 Hellmut Dr Augustin Verfahren zur Früherkennung gestosegefährdeter schwangerer Frauen
EP0977585A4 (en) * 1997-01-24 2001-04-11 Blood Res Center METHOD FOR DIAGNOSING AND TREATING WEIGHT PROBLEMS IN ANIMALS
DE69829995T2 (de) * 1997-12-01 2006-02-23 Fang, Fang, San Diego Multivalente rekombinante antikörper zur behandlung von hrv infektionen
DE19845617A1 (de) * 1998-03-02 1999-09-30 Johannes Eichenauer Verfahren zur Kontrolle inflammatorischer Reaktionen medizinischer Behandlungen
US20030035798A1 (en) * 2000-08-16 2003-02-20 Fang Fang Humanized antibodies
US6670321B1 (en) 1998-12-30 2003-12-30 The Children's Medical Center Corporation Prevention and treatment for retinal ischemia and edema
US6150121A (en) * 1999-02-16 2000-11-21 Wisconsin Alumni Research Foundation Assessing immunological state of transplant recipients
WO2001051084A1 (en) * 2000-01-14 2001-07-19 Genentech, Inc. Diagnosis and treatment of hepatic inflammatory disorders by inhibiting the binding of lfa-1 to icam-1
CA2898314A1 (en) 2001-07-19 2003-07-31 Perian Therapeutics, Inc. Multimeric proteins and methods of making and using same
SE0402536D0 (sv) * 2004-10-20 2004-10-20 Therim Diagnostica Ab Immunoregulation in cancer, chronic inflammatory and autoimmune diseases
US8026343B2 (en) * 2008-08-08 2011-09-27 Dinona Inc. Antibody modulating the differentiation and function of dendritic cells via binding intercellular adhesion molecule-1 and use thereof
KR101434029B1 (ko) * 2012-09-14 2014-08-26 서울대학교산학협력단 Ｉｃａｍ－1에 대한 항체 및 그 용도
CN103698537A (zh) * 2014-01-06 2014-04-02 天津医科大学总医院 定量检测人血清可溶性细胞间粘附分子-1的化学发光免疫分析试剂盒及检测方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4244940A (en) * 1978-09-05 1981-01-13 Bio-Rad Laboratories, Inc. Single-incubation two-site immunoassay
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
ES2080044T3 (es) * 1987-05-04 1996-02-01 Dana Farber Cancer Inst Inc Moleculas de adhesion intercelular y sus ligandos de fijacion.
EP0314863B1 (en) * 1987-11-02 1994-12-07 Baylor College Of Medicine Use of ICAM-1 or its functional derivatives for the treatment of non-specific inflammation
US5235049A (en) * 1989-01-24 1993-08-10 Molecular Therapeutics, Inc. Nucleic acid sequences encoding a soluble molecule (SICAM-1) related to but distinct from ICAM-1
HU217792B (hu) * 1989-03-16 2000-04-28 Dana Farber Cancer Institute Eljárás intercelluláris adhéziós molekula (ICAM-1) oldható származékai és ezeket tartalmazó gyógyszerkészítmények előállítására
GB9009549D0 (en) * 1990-04-27 1990-06-20 Celltech Ltd Recombinant antibody and method
GB9009548D0 (en) * 1990-04-27 1990-06-20 Celltech Ltd Chimeric antibody and method
US5223396A (en) * 1991-05-03 1993-06-29 Boehringer Ingelheim Pharmaceuticals, Inc. Method for detecting organ transplant rejection

Also Published As

Publication number Publication date
EP0512301A1 (en) 1992-11-11
DE69204732T2 (de) 1996-03-21
JP3226323B2 (ja) 2001-11-05
AU664367B2 (en) 1995-11-16
US5223396A (en) 1993-06-29
CA2067916A1 (en) 1992-11-04
ATE127926T1 (de) 1995-09-15
HK1003124A1 (en) 1998-10-09
ES2077909T3 (es) 1995-12-01
EP0512301B1 (en) 1995-09-13
GR3018162T3 (en) 1996-02-29
DE69204732D1 (de) 1995-10-19
NZ242603A (en) 1993-07-27
JPH05149948A (ja) 1993-06-15
CA2067916C (en) 2004-04-20
AU1598692A (en) 1992-11-05
US5354659A (en) 1994-10-11
ZA923167B (en) 1993-03-31
US5472849A (en) 1995-12-05

Similar Documents

Publication Publication Date Title
DK0512301T3 (da) Fremgangsmåde til påvisning af inflammation
DK0779984T3 (da) Optisk læsbar strimmel til analytpåvisning med en standard på strimlen
ES2186836T3 (es) Uso de cristales liquidos termocromicos en procedimientos de diagnostico basados en reflectometria.
SE9702118D0 (sv) Blodanalyssystem
DK0799896T3 (da) Reagensprøvestrimmel til bestemmelse af blodglucose
WO2005001462A8 (en) System and method for determining an abused sensor during analyte measurement in a biological fluid
AU8583491A (en) Monitoring and dosage control of tagged polymers in cooling water systems
DK570487D0 (da) In vivo cellesporing
NO971009L (no) Posisjonsdetekterbar remse for analytt deteksjon
Machida et al. Measurement of carvedilol in plasma by high-performance liquid chromatography with electrochemical detection
IL112146A0 (en) Test device and method for the detection of protein in a biological sample
CA2149903A1 (en) Use of capillary electrophoresis for quantitating the concentration of protein components and of the total protein in fluids
DK156926C (da) Fremgangsmaade til paavisning af tilstedevaerelsen af et antigen eller antistof i en proevevaeske ved maaling af erythrocytsedimentation og proevesaet til udfoerelse af fremgangsmaaden
EP1197744A3 (en) Solution concentration measuring method and solution concentration measuring aparatus
DE69322242D1 (de) Turbidimetrisches Immunassay mit Messung der Geschwindigkeit der Trübungsveränderung nach dem Anfang der Immunpräzipitationsreaktion
FI843209A (fi) Foerfarande och anordning foer maetning av halten suspenderade substanser i ett stroemmande medium.
SE9300231D0 (sv) Foerbaettrad metod foer brytningsindexdetektion i vaetska
SE9802852D0 (sv) Fluid sensing device and method for use in particular in milking machines
KR950009227A (ko) 광흡수를 이용한 농도측정방법
FI915285A0 (fi) Menetelmä näytteiden mittaamiseksi nestetuikelaskimella ja nestetuikelaskin
JPS5697864A (en) Method and apparatus for analyzing glutamic oxalacetic trans-aminase
JPS5682437A (en) Concentration measuring apparatus of solution of colored matter
Barczewski et al. INVESTIGATION ON A FLOWRATE MEASURING SYSTEM USING LIGHT FIBRE FLUOROMETERS
JPH04135547A (ja) 光センサ
SU1602175A1 (ru) Способ корреляционного анализа газов